Highly sensitive detection of protein biomarkers via nuclear magnetic resonance biosensor with magnetically engineered nanoferrite particles
Authors Jeun M, Park S, Lee H, Lee KH
Received 26 July 2016
Accepted for publication 8 October 2016
Published 21 October 2016 Volume 2016:11 Pages 5497—5503
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 6
Editor who approved publication: Prof. Dr. Thomas J. Webster
Minhong Jeun,1 Sungwook Park,1,2 Hakho Lee,3 Kwan Hyi Lee1,2
1Center for Biomaterials, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul, 2Department of Biomedical Engineering, Korea University of Science and Technology, Daejeon, Republic of Korea; 3Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
Abstract: Magnetic-based biosensors are attractive for on-site detection of biomarkers due to the low magnetic susceptibility of biological samples. Here, we report a highly sensitive magnetic-based biosensing system that is composed of a miniaturized nuclear magnetic resonance (NMR) device and magnetically engineered nanoferrite particles (NFPs). The sensing performance, also identified as the transverse relaxation (R2) rate, of the NMR device is directly related to the magnetic properties of the NFPs. Therefore, we developed magnetically engineered NFPs (MnMg-NFP) and used them as NMR agents to exhibit a significantly improved R2 rate. The magnetization of the MnMg-NFPs was increased by controlling the Mn and Mg cation concentration and distribution during the synthesis process. This modification of the Mn and Mg cation directly contributed to improving the R2 rate. The miniaturized NMR system, combined with the magnetically engineered MnMg-NFPs, successfully detected a small amount of infectious influenza A H1N1 nucleoprotein with high sensitivity and stability.
Keywords: biosensor, NMR, nanoferrite particles, transverse relaxation, magnetization, on-site detection
On-site detection for rapid initial examination regarding possible virus infection is critical in preventing serious contagions. Accordingly, there has been an increase in the development of sensitive biosensor systems that include electrical, optical, and magnetic-based mechanisms.1–6 In particular, the magnetic-based sensing system is an attractive method for biosensor applications. This is possible because intrinsically biological media have low magnetic susceptibility. Consequently, the magnetic sandwich assay can achieve a high detection signal with low interferences even in a complex biological background.7
Nuclear magnetic resonance (NMR) is a useful magnetic-based sensing technology that enables rapid, stable, and highly sensitive biomarker detection by utilizing magnetic resonance technology to detect biomarkers labeled with magnetic particles.8,9 The transverse relaxation (R2) rate of the water protons in the vicinity of the magnetic particles and the target biomarker is modified upon reacting with the magnetic particles, and this change can be detected by the NMR. The biomarkers labeled with magnetic particles exhibit a faster decay rate (larger R2) of NMR signals than that of non-magnetic particle-labeled biomarkers.10–12 The NMR-based detection technology requires minimal sample purification steps and consequently reduces sample loss. In addition, because the NMR signal is generated from the whole volume, the binding kinetics for the NMR signal is much quicker than that of surface reaction-based sensors. This allows the NMR assay the advantage of obtaining a rapid sensing signal at a faster pace. Naturally, the NMR signal is directly relevant to the magnetic particles. Because magnetic particles with a higher R2 rate can improve the detection sensitivity in NMR-based sensing, developing a magnetic NMR agent that exhibits a higher R2 rate is imperative in achieving maximal sensitivity in the NMR sensing.
In this study, we developed a high-performance magnetic particle to improve the NMR sensitivity and then demonstrated its feasibility as an NMR agent by conducting a detection test for the nucleoproteins of the influenza A H1N1 virus. In order to achieve this goal, we magnetically engineered Fe-nanoferrite particles (Fe-NFPs) to enhance the R2 rate. The Fe ions in tetrahedral A (TA) sites or octahedral B (OB) sites were substituted with Mn ions (Mn-NFPs) and Mn/Mg ions (MnMg-NFPs) for increased magnetization; the R2 rate of the NFPs is proportional to the magnetization (R2 ≈ d2M2; d represents the diameter of the nanoparticle).13
Materials and methods
Synthesis of nanoferrites and surface modification
All the NFPs were synthesized using a high temperature thermal decomposition method.14,15 The metal precursors (Fe (III) acetylacetonate [(C5H8O2)3Fe] (>99.9%), Mn (II) acetate tetrahydrate [(CH3COO)2Mn4H2O] (99.99%) and Mg acetate tetrahydrate [(C2H3O2)2Mg4H2O] (99.999%)) and other materials such as the surfactants (oleic acid [C18H34O2] (90%), oleylamine [C18H37N] (70%)), reducing agents (1,2-hexadecanediol [CH3(CH2)13CH(OH)CH2OH] (90%)), and solvent (benzyl ether [C14H14O] (99%)) were mixed and heated up to 296°C.11 The Mn and Mg cation concentration and distribution in Mn-NFPs and MnMg-NFPs were chemically controlled by adjusting the amount of the Mn and Mg precursors and the amount of the reducing agent during the synthesis process. Then, all the synthesized NFPs were rendered water soluble by coating the surface of particles with polyethylene glycol (PEG).
Water-soluble NFPs were obtained by forming a lipid layer (PEGylated lipid) with 1-myristoyl-2-hydroxy-sn-glycero-3-phosphocholine/1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(lauroyl)-polyethylene glycol 2000 (MHPC/DSPE-PEG2K). The NFPs were conjugated with influenza A H1N1 nucleoprotein antibodies. The reaction of the primary amines on the antibody with PEG-coated NFPs ([email protected]) was catalyzed by 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride and sulfo-N-hydroxysuccinimide. More detailed protocols regarding the surface modification of NFPs and antibody conjugation with NFPs are indicated in our previous reports.16–18
Characterization of nanoferrites
The size and size distribution of the synthesized NFPs were measured by transmission electron microscopy. The hydrodynamic diameter (dH) and polydispersity index (PDI) of the [email protected] were measured using a dynamic light scattering system. The magnetic hysteresis characteristics, including the major and minor hysteresis loops for both the non-coated (powder state) and PEG-coated (fluid state) NFPs, were investigated using a vibrating sample magnetometer. The R2 rate was measured by employing a miniaturized NMR system.19 The NMR system consists of three components, microcoils, on-board NMR electronics, and a small permanent magnet. The permanent magnet can be used to generate polarizing magnetic field, B0 =0.1–0.5 T. The concentrations of NFPs for the measurement of R2 rate were varied from 10−2 to 10−11 g/mL.
The biosensing performances, including sensitivity and limit-of-detection (LOD) of the NFPs, were evaluated by detecting the nucleoproteins of influenza A H1N1 virus using the miniaturized NMR system combined with the magnetic sandwich method. The H1N1 nucleoprotein and antibody to the H1N1 nucleoproteins were purchased from Sino Biological Inc. A total of 15 μL of the H1N1 nucleoprotein mixture solution was first mixed with polystyrene beads (diameter: 3 μm) conjugated with the capture antibody and incubated for 30 min at room temperature. Uncaptured H1N1 nucleoproteins were removed by washing the beads with the wash buffer. The NFPs conjugated with detection antibody were then added, and the mixture was incubated again for 20 min. The unbound NFPs were removed by washing and filtering the mixture with the wash buffer, and finally, 15 μL of phosphate-buffered saline (PBS) was added to the mixture for NMR measurement (Scheme 1). We carried out all R2 measurements at the polarizing magnetic field of B0 =0.5 T. All the measurements were done in triplicate at room temperature.
Scheme 1 Schematic illustration to show the detecting procedure for the influenza A H1N1 nucleoprotein using the miniaturized NMR system.
Results and discussion
As the coating and dispersion status of the particles inside the fluid affects the magnetic properties, we investigated the PEG coating status for all the PEG-coated NFPs ([email protected]). All the [email protected] had a similar size, size distribution, and PDI. As can be seen in Figure 1A–C, all the [email protected] dispersed in deionized (DI) water had similar small-sized nanoferrite cores (diameter: 7–10 nm) and uniform dH of 35.3–37.5 nm with a narrow size distribution of ~10.16% and low PDI values in the range of 1.15–1.28, indicating that the NFPs were uniformly coated with the PEG and that the [email protected] were well dispersed in DI water with minimal aggregation.
Figure 2 shows the direct current (DC) magnetic hysteresis loops of the A powder state and the B fluid state of the NFPs measured at room temperature. The synthesized NFPs did not show any DC minor hysteresis at the sweeping field of ±140 Oe, indicating that all the nanoparticles synthesized in this study have a pure superparamagnetic phase (Figure 2A inset). Among all the NFPs, in particular, the MnMg-NFPs showed a higher magnetization than that of the Mn-NFPs and Fe-NFPs. This result implies that the MnMg-NFPs are magnetically softer and have a lower magnetic anisotropy (or a higher DC magnetic susceptibility, χm) than that of the Mn-NFPs and Fe-NFPs. Considering that the preferential site of Mn2+ cations is the OB site of Fe-NFPs, the improved magnetization of Mn-NFPs is physically thought to be due to the possible substitution of Fe2+ cations with 4 μB (Bohr magneton) in the OB sites by Mn2+ cations with 5 μB during the synthesis process (Figure 2C).
In the case of the MnMg-NFPs, where the preference site of Mg2+ cations is the TA site, the Mg2+ cations (μB =0) replace the Fe2+ cations in the TA site of Mn-NFPs, and as a result, the magnetic moment of the MnMg-NFPs increases (6.2 μB, total net μB = μB [OB site] − μB [TA site]). The fluid state [email protected] (Figure 2B) also retains the superparamagnetic phase and stable DC magnetic hysteresis loops. This is due to the superior PEG coating status, which allows for a more uniform anti-body conjugation to the [email protected] without spontaneous magnetic aggregation.20,21
The R2 characteristic of each [email protected] was measured using the miniaturized NMR system in a magnetic field B0 (0.5 T) to evaluate the feasibility as an NMR agent for the detection of H1N1 nucleoproteins. In order to measure the R2 rate, [email protected], [email protected], and [email protected] were dispersed in DI water. The concentration of the [email protected] dispersed in DI water varied from 5×10−2 g/mL to 5×10−10 g/mL. Figure 3 shows the R2 values for the three [email protected] at various concentrations. The observed R2 values increased as the concentration increased, and the [email protected] exhibited the highest R2 value among the different [email protected]
Figure 3 Transverse relaxation (R2) rate of all the [email protected] depending on the concentration.
Considering the fact that the R2 is proportional to magnetization (R2 ≈ d2M2), the highest R2 value of the [email protected] is thought to be due to the highly improved magnetization caused by engineering the cation concentration and distribution in the NFPs. This result demonstrates that the [email protected] is high enough to be considered as an NMR agent.
In order to demonstrate the applicability of the engineered NFPs as an NMR agent, we used the [email protected] and the [email protected] to detect H1N1 nucleoproteins in a miniaturized NMR system. Figure 4A shows the miniaturized NMR system and representative NMR signal (T2 time of [email protected]). Figure 4B exhibits the H1N1 nucleoprotein detection ability (ΔR2 = R2,P-beads + H1N1 + NFPs − R2,P-beads) of the [email protected] and [email protected] Both [email protected] successfully detected the amount of H1N1 nucleoprotein with a low error range of <4.5%. The H1N1 nucleoproteins bound to a polystyrene bead can be a cause of the aggregation of NFPs and the corresponding increase in the R2 rate.
Figure 4 (A) Miniaturized NMR system and representative measured NMR signal (T2 time). (B) Detection results of influenza A H1N1 nucleoprotein using the miniaturized NMR system with [email protected] and [email protected] The [email protected] and [email protected] are conjugated with the detection antibodies and used as an NMR agent. The polystyrene bead is conjugated with the capture antibodies.
As can be clearly seen in the result, the [email protected] showed a significantly higher ΔR2, a wider dynamic range, and a lower LOD than those of [email protected] The [email protected] showed a ΔR2 of 0.501 s−1(g/mL)−1 with an LOD of 1×10−9 g/mL, while the Fe-NFPs exhibited a ΔR2 of 0.329 s−1(g/mL)−1 with an LOD of 1×10−7 g/mL. All the results strongly demonstrate that the magnetically engineered MnMg-NFPs have the potential to be a promising NMR agent for the detection of viral biomarkers with high sensitivity and stability.
We developed the magnetically engineered MnMg-NFPs for application as an NMR agent to detect infectious viruses. The Mn and Mg cation concentration and distribution in the MnMg-NFPs were chemically controlled during the Fe-NFP synthesis to improve the magnetization of spinel-structured NFPs. As a result, the MnMg-NFPs showed the highest magnetization value among the prepared NFPs, as well as a correspondingly improved R2 rate. The potential of the MnMg-NFPs as an NMR agent was demonstrated by conducting the H1N1 nucleoprotein detection test. The MnMg-NFPs successfully detected a tiny amount of H1N1 nucleoproteins in PBS with a stable and high R2 rate (high sensitivity).
This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A6A3A04063923), the Bio & Medical Technology Development Program of the NRF funded by the Korean government MSIP (2015M3A9E2029265), and Korea Health Technology R&D Project through the Korea Health Industry Development Institute funded by the Ministry of Health and Welfare, Republic of Korea (HI15C-3078-020015).
The authors report no conflicts of interest in this work.
Allegranzi B, Nejad SB, Combescure C, et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet. 2011;377(9761):228–241.
Nguyen TT, Bea SO, Kim DM, et al. A regenerative label-free fiber optic sensor using surface plasmon resonance for clinical diagnosis of fibrinogen. Int J Nanomedicine. 2015;10(Spec Iss):155–163.
Klompas M, Yokoe DS. Automated surveillance of health care-associated infections. Clin Infect Dis. 2009;48(9):1268–1275.
Apetrei IM, Apetrei C. Voltammetric determination of melatonin using a graphene-based sensor in pharmaceutical products. Int J Nanomedicine. 2016;11:1859–1866.
Polin RA, Denson S, Brady MT, Newborn CF, Dis CI. Epidemiology and diagnosis of health care-associated infections in the NICU. Pediatrics. 2012;129(4):1104–1109.
Mers SS, Kumar ET, Ganesh V. Gold nanoparticles-immobilized, hierarchically ordered, porous TiO2 nanotubes for biosensing of glutathione. Int J Nanomedicine. 2015;10(suppl 1):171–182.
Min C, Shao HL, Liong M, Yoon TJ, Weissleder R, Lee H. Mechanism of magnetic relaxation switching sensing. ACS Nano. 2012;6(8):6821–6828.
Lee H, Yoon TJ, Figueiredo JL, Swirski FK, Weissleder R. Rapid detection and profiling of cancer cells in fine-needle aspirates. Proc Natl Acad Sci U S A. 2009;106(30):12459–12464.
Lee H, Yoon TJ, Weissleder R. Ultrasensitive detection of bacteria using core-shell nanoparticles and an NMR-filter system. Angew Chem Int Edit. 2009;48(31):5657–5660.
Gillis P, Koenig SH. Transverse relaxation of solvent protons induced by magnetized spheres – application to ferritin, erythrocytes, and magnetite. Magn Reson Med. 1987;5(4):323–345.
Koenig SH, Kellar KE. Theory of 1/T1 and 1/T2 NMRD profiles of solutions of magnetic nanoparticles. Magn Reson Med. 1995;34(2):227–233.
Yang HC, Liu CW, Liao SH, et al. Temperature and concentration-dependent relaxation of ferrofluids characterized with a high-Tc SQUID-based nuclear magnetic resonance spectrometer. Appl Phys Lett. 2012;100(20):202405–202408.
Gillis P, Moiny F, Brooks RA. On T2-shortening by strongly magnetized spheres: a partial refocusing model. Magn Reson Med. 2002;47(2):257–263.
Jeun M, Park S, Jang GH, Lee KH. Tailoring MgxMn1-xFe2O4 superparamagnetic nanoferrites for magnetic fluid hyperthermia applications. ACS Appl Mater Inter. 2014;6(19):16487–16492.
Jeun M, Moon SJ, Kobayashi H, et al. Effects of Mn concentration on the ac magnetically induced heating characteristics of superparamagnetic MnxZn1-xFe2O4 nanoparticles for hyperthermia. Appl Phys Lett. 2010;96:202511–202513.
Kim C, Galloway JF, Lee KH, Searson PC. Universal antibody conjugation to nanoparticles using the Fcγ receptor I (FcγRI): quantitative profiling of membrane biomarkers. Bioconjug Chem. 2014;25(10):1893–1901.
Hwang MP, Lee JW, Lee KE, Lee KH. Think modular: a simple apoferritin-based platform for the multifaceted detection of pancreatic cancer. ACS Nano. 2013;7(9):8167–8174.
Jang GH, Hwang MP, Kim SY, Jang HS, Lee KH. A systematic in-vivo toxicity evaluation of nanophosphor particles via zebrafish models. Biomaterials. 2014;35(1):440–449.
Lee H, Sun E, Ham D, Weissleder R. Chip-NMR biosensor for detection and molecular analysis of cells. Nat Med. 2008;14(8):869–874.
Jun YW, Lee JH, Cheon J. Chemical design of nanoparticle probes for high-performance magnetic resonance imaging. Angew Chem Int Edit. 2008;47(28):5122–5135.
Laurent S, Forge D, Port M, et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev. 2008;108(6):2064–2110.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]